MKT Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $544K | Sell |
2,866
-14
| -0.5% | -$2.66K | 0.22% | 69 |
|
2025
Q1 | $537K | Sell |
2,880
-75
| -3% | -$14K | 0.25% | 58 |
|
2024
Q4 | $507K | Sell |
2,955
-84
| -3% | -$14.4K | 0.22% | 68 |
|
2024
Q3 | $598K | Sell |
3,039
-193
| -6% | -$38K | 0.28% | 58 |
|
2024
Q2 | $543K | Sell |
3,232
-46
| -1% | -$7.73K | 0.27% | 65 |
|
2024
Q1 | $554K | Sell |
3,278
-14
| -0.4% | -$2.37K | 0.3% | 61 |
|
2023
Q4 | $534K | Sell |
3,292
-220
| -6% | -$35.7K | 0.35% | 58 |
|
2023
Q3 | $521K | Sell |
3,512
-28
| -0.8% | -$4.15K | 0.39% | 55 |
|
2023
Q2 | $534K | Sell |
3,540
-213
| -6% | -$32.1K | 0.38% | 55 |
|
2023
Q1 | $603K | Buy |
3,753
+13
| +0.3% | +$2.09K | 0.45% | 50 |
|
2022
Q4 | $588K | Sell |
3,740
-134
| -3% | -$21.1K | 0.44% | 54 |
|
2022
Q3 | $520K | Sell |
3,874
-34
| -0.9% | -$4.56K | 0.45% | 53 |
|
2022
Q2 | $599K | Buy |
3,908
+2
| +0.1% | +$307 | 0.47% | 47 |
|
2022
Q1 | $590K | Buy |
3,906
+138
| +4% | +$20.8K | 0.45% | 49 |
|
2021
Q4 | $506K | Buy |
+3,768
| New | +$506K | 0.4% | 53 |
|